NSN 6505-01-696-1752 · NIIN 016961752 · FSC 6505
NO DASHES 6505016961752
In Stock
BRINCIDOFOVIR TABLETS
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | BRINCIDOFOVIR TABLETS, 4S, 100MG |
| FEAT | SPECIAL FEATURES | INDICATED FOR THE TREATMENT OF HUMAN SMALLPOX DISEASE CAUSED BY VARIOLA VIRUS IN ADULT AND PEDIATRIC PATIENTS, INCLUDING NEONATES; TABLETS ARE BLUE, MODIFIED-OVAL SHAPE, FILM-COATED TABLETS DEBOSSED WITH BCV ON ONE SIDE AND 100 ON THE OTHER SIDE AND PACKAGED INTO BLISTER CARDS; CONTAINS ONE (1) BLISTER CARD WITH A TOTAL OF 4 FILM-COATED TABLETS; STORE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED FROM 15 C TO 30 C (59 F TO 86 F. (SEE USP CONTROLLED ROOM TEMPERATURE); FOR ORAL USE; DO NOT DIVIDE, BREAK, OR CRUSH THE TABLETS; SHELF LIFE: 24 MONTHS. |